The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Young Matthew P. since 2017.
The trader's CIK number is 1601583.
At the time of the last reporting, Young Matthew P. was the Director of Jazz Pharmaceuticals Plc. (stock ticker symbol JAZZ).
Also see all insider trading activities at Jazz Pharmaceuticals Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | PRAH | 0 | $0 | 5,115 | $408,688 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | JAZZ | 0 | $0 | 3,068 | $407,863 | 0 | $0 |
| 2018 | JAZZ | 0 | $0 | 17,007 | $2,729,853 | 5,000 | $293,600 |
1. Pra Health Sciences, Inc. (PRAH)
2. Jazz Pharmaceuticals Plc (JAZZ)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-16 | PRAH | Sale | 5,115 | 79.90 | 408,688 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-06 | JAZZ | Sale | 1,152 | 135.41 | 155,992 |
| 2019-02-27 | JAZZ | Sale | 884 | 137.91 | 121,912 |
| 2019-02-26 | JAZZ | Sale | 1,032 | 125.93 | 129,959 |
| 2018-11-23 | JAZZ | Sale | 700 | 150.00 | 105,000 |
| 2018-10-15 | JAZZ | Sale | 700 | 158.08 | 110,658 |
| 2018-09-17 | JAZZ | Sale | 700 | 162.70 | 113,889 |
| 2018-08-15 | JAZZ | Sale | 700 | 176.05 | 123,235 |
| 2018-07-16 | JAZZ | Sale | 700 | 176.06 | 123,242 |
| 2018-06-15 | JAZZ | Sale | 700 | 176.99 | 123,893 |
| 2018-06-01 | JAZZ | Sale | 5,000 | 170.04 | 850,210 |
| 2018-06-01 | JAZZ | Option Ex | 5,000 | 58.72 | 293,600 |
| 2018-05-15 | JAZZ | Sale | 1,420 | 164.64 | 233,788 |
| 2018-04-16 | JAZZ | Sale | 700 | 156.01 | 109,207 |
| 2018-03-15 | JAZZ | Sale | 700 | 151.22 | 105,854 |
| 2018-03-06 | JAZZ | Sale | 1,152 | 142.55 | 164,217 |
| 2018-02-27 | JAZZ | Sale | 1,916 | 146.03 | 279,793 |
| 2018-02-28 | JAZZ | Sale | 1,219 | 147.95 | 180,355 |
| 2018-01-16 | JAZZ | Sale | 700 | 152.16 | 106,512 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Young Matthew P. (Director of Jazz Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.